MINNEAPOLIS, Aug. 15 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex:
UPI) announced today that David Kaysen, President and CEO, and Medi Jiwani,
Vice President, CFO & Treasurer, will present at the Roth Capital Partners'
Investor Conference at the Times Square Westin Hotel in New York, on
September 5, 2007 at 3.00 pm central time. Presentation slides will
available for viewing on Uroplasty's website (http://www.uroplasty.com)
starting at 3.00 pm central time on September 5, 2007.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with
wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a
medical device company that develops, manufactures and markets innovative,
proprietary products for the treatment of voiding dysfunctions. Our
minimally invasive products treat urinary and fecal incontinence, symptoms
of overactive bladder and vesicoureteral reflux. Additionally, some of our
soft-tissue bulking agent products are used for the treatment of vocal cord
rehabilitation and for augmentation or restoration of soft tissue defects
in plastic surgery indications. Some of our products are not approved for
use in the U.S.
FOR FURTHER INFORMATION: visit Uroplasty's web page at
http://www.uroplasty.com or contact Mr. Kaysen, President & CEO, or Medi
Jiwani, Vice President, CFO and Treasurer.
UROPLASTY, INC.
5420 Feltl Road
Minnetonka, Minnesota 55343
Tel: 952.426.6140
Fax: 952.426.6199
SOURCE Uroplasty, Inc.
 back to top
Related links:
http://www.uroplasty.com
CONTACT:
Mr. Kaysen, President & CEO, or Medi Jiwani,
Vice President, CFO and Treasurer, +1-952-426-6140, fax,
+1-952-426-6199, both of Uroplasty, Inc.
|
